Tampa

The trials here

What the 16 trials at this site are about, from their registry records.

Conditions

• Asthma3 trials
• COPD2 trials
• HIV2 trials
• Lung cancer2 trials
• Ovarian cancer2 trials
• Chronic rhinosinusitis with nasal polyps1 trial
• Colorectal cancer1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Hepatitis B1 trial
• Irritable bowel syndrome1 trial
• Liver and biliary tract cancer1 trial
• Lupus (SLE)1 trial
• and 2 more

Phase

• Phase 25 trials
• Phase 14 trials
• Phase 34 trials
• Phase 42 trials
• Phase 1/21 trial

Status

• Active, not recruiting6 trials
• Recruiting6 trials
• Completed3 trials
• Terminated1 trial

Lead sponsor

• GlaxoSmithKline10 trials
• Tesaro, Inc.4 trials
• ViiV Healthcare2 trials

Running trials

• Recruiting

  A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

  NCT07780656· Phase 3· GlaxoSmithKline· Source

  Contact: Sady Alpizar (principal investigator)

• Recruiting

  A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)

  NCT07782996· Phase 3· GlaxoSmithKline· Source

  Contact: Manuel Gomez (principal investigator)

• Recruiting

  A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

  NCT07519395· Phase 2· GlaxoSmithKline· Source

  Contact: Sady Alpizar (principal investigator)

• Recruiting

  A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

  NCT07358546· Phase 1· GlaxoSmithKline· Source

  Contact: Jesus Navarro (principal investigator)

• Active, not recruiting

  A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

  NCT07168356· Phase 1· GlaxoSmithKline· Source

• Recruiting

  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  NCT06959095· Phase 3· GlaxoSmithKline· Source

  Contact: GERMAN ALVAREZ (principal investigator)

• Active, not recruiting

  A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma

  NCT06748053· Phase 2· GlaxoSmithKline· Source

• Active, not recruiting

  A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

  NCT06411249· Phase 4· GlaxoSmithKline· Source

• Recruiting

  Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

  NCT05674656· Phase 1/2· ViiV Healthcare· Source

  Contact: Carina Rodriguez (principal investigator)

• Active, not recruiting

  Extended Access of Momelotinib in Adults With Myelofibrosis

  NCT03441113· Phase 2· GlaxoSmithKline· Source

• Active, not recruiting

  A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

  NCT02817633· Phase 1· Tesaro, Inc.· Source

• Active, not recruiting

  Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

  NCT02715284· Phase 1· Tesaro, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD2 recruiting
• Asthma1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• HIV1 recruiting
• Irritable bowel syndrome1 recruiting

Closed trials

• Completed

  A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

  NCT05514509· Phase 4· ViiV Healthcare· Source

• Completed

  Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

  NCT05274750· Phase 3· GlaxoSmithKline· Source

• Terminated

  A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C)

  NCT06964165· Phase 2· Tesaro, Inc.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian Cancer

  NCT03574779· Phase 2· Tesaro, Inc.· Source